-
CureDuchenne Announces Fuerza 2025: A Landmark Conference in Mexico City on October 25 Focused on Duchenne and Becker Muscular Dystrophy
Full-Day Conference Will Bring Education, Support, and Connection to Families and Healthcare Providers Serving the […]
-
WEBINAR: Avidity EXPLORE44-OLE Functional Data Update
Avidity reports multiple functional improvements with Del-zota for individuals with Duchenne amenable to skipping exon […]
-
MDA Ambassador Guest Blog: Better All the Time: Fighting Against Bitterness
Chase Rankin was diagnosed with Friedreich’s ataxia in the 7th grade. He is now a […]
-
With DMD, the transition to adulthood brings many unknowns
One thing I love about living in the Midwest is enjoying all four seasons. The […]
-
DM1 gene therapy trial seeks patients ages 10-50
A Phase 1/2 clinical trial testing SAR446268, an experimental gene therapy for myotonic dystrophy type […]
-
Hormone combination therapy delivers gains for men with FSHD
A combined regimen of testosterone and growth hormone led to significant improvements in muscle mass, […]
-
WEBINAR: Edgewise
A Fireside Chat with Mike Kelly and Edgewise Therapeutics: A Duchenne Program Update Wednesday, September […]
-
MDA Ambassador Guest Blog: The Unequivocal Power of Using Your Voice
Living in Pennsylvania with her son, Victoria is an active volunteer with the Speak Foundation […]
-
CureDuchenne and Rady Children’s Health Come Together to Dedicate CureDuchenne Clinic and Expand Care for Children with Duchenne and Becker Muscular Dystrophy
Ribbon-Cutting Ceremony Marks a Major Step Forward in Expanding Access to Advanced Care and Cutting-Edge […]
-
No isn’t an option when living with Duchenne muscular dystrophy
In recognition of Duchenne Muscular Dystrophy Awareness Month in September, the Duchenne Muscular Dystrophy Community […]
